Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Compiled: 3-71 Discussion 09/29/19

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 316
Posts 40,631
Boards Moderated 29
Alias Born 09/20/01
160x600 placeholder
Anavex Life Sciences Announces Achievement of Enrollment Target for the ANAVEX®2-73 (blarcamesine) Phase 2 Parkinson’s Dis... GlobeNewswire Inc. - 1/27/2020 7:00:10 AM
Anavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrom... GlobeNewswire Inc. - 1/8/2020 7:00:10 AM
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 12/16/2019 7:00:10 AM
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019 GlobeNewswire Inc. - 12/10/2019 7:00:10 AM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 7:23:11 AM
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Con... GlobeNewswire Inc. - 12/4/2019 7:00:10 AM
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment o... GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome GlobeNewswire Inc. - 11/6/2019 7:00:00 AM
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease GlobeNewswire Inc. - 10/9/2019 7:00:00 AM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’... GlobeNewswire Inc. - 10/2/2019 7:00:00 AM
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from th... GlobeNewswire Inc. - 9/27/2019 3:00:00 AM
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/23/2019 6:35:19 AM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/18/2019 7:00:00 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/17/2019 5:16:10 PM
CLS Holdings (CLSH) $1.15 Price Target - MASS Approval for Recreational License InvestorsHub NewsWire - 9/17/2019 7:17:00 AM
Withdrawal of Registration Statement (ammendment) (aw) Edgar (US Regulatory) - 9/16/2019 4:17:42 PM
Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patie... GlobeNewswire Inc. - 9/16/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 5:11:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/13/2019 5:07:24 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/13/2019 5:02:44 PM
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019 GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study in Pediatric Patients with Ret... GlobeNewswire Inc. - 9/4/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:07:28 PM
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 8/7/2019 7:00:00 AM
XenaLives Member Level  Sunday, 09/29/19 11:49:27 AM
Re: None
Post # of 232712 
Compiled: 3-71 Discussion 09/29/19
_____________________________________________________________________________________________

Transgenic rat model:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151290355

3-71 and Alzheimer's
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151290584

Falconer on commonalities of CNS disease:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145055598

Opportunities for treatment with Anavex 2-73 and/or Anavex 3-71 (from georgejjl)

Image from AVXL presentation, clipped by georgej

Origin of 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148063609

3-71 preclinical and IP information:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148063670

3-71 is more potent:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149158581&txt2find=71

AF710B (aka ANAVEX 3-71) preclinical studies (from georgejjl)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409318/
Comments on the above:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148105642
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148106820
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148110087

Biostockclub - on comparison of 2-73 and 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147042220
(see response by Falconer66a also)


Seminal Findings in the Anavex 3-71 Rat Study
(from falconer66a)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147056303

3-71 articles from McGill coming:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147109223

ANAVEX 3-71 additional information from 2016 (from georgejjl)
https://www.karger.com/Article/Fulltext/440864

Anavex 2-73 and Anavex 3-71 as a treatment for PTSD (Posttraumatic Stress Disorders)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148757940&txt2find=71

On the science of 3-71
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147390529

McGill Powerpoint on 3-71 (from georgejjl)
https://anavex.com/wp-content/uploads/170330_ADPD-Vienna_HH-update.pdf

2-73 vs 3-71 and the new sleep post tying taupathologies to sleep and synaptic loss
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147042220

Why 2-73 was first (maybe):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147015651


Murine data show 3-71 to be even more powerful than Anavex 2-73

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146991629


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist